Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2.

Journal of biomolecular structure & dynamics - 1 Jan 2000

Priya Prerna, Basit Abdul, Bandyopadhyay Pradipta

Abstract excerpt

The SARS-CoV-2 virus has caused high-priority health concerns at a global level. Vaccines have stalled the proliferation of viruses to some extent. Yet, the emergence of newer, potentially more infectious, and dangerous mutants such as Delta and Omicron are among the major challenges in finding a more permanent solution for this pandemic. The effectiveness of antivirals Molnupiravir and Paxlovid, authorized for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acids
Share to COVID-19
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peptides

Share to Protein Binding

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Identifiers

PMID: 35881159
DOI: 10.1080/07391102.2022.2103587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2.PMID 35881159Read ↗

A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2Semantic proximity Read ↗

Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern.Semantic proximity Read ↗

Molecular recognition of SARS-CoV-2 spike protein with three essential partners: exploring possible immune escape mechanisms of viral mutants.Semantic proximity Read ↗

A novel peptide analogue of spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico approach through molecular docking, molecular dynamics simulation and MM-PB/GBSA calculationsSemantic proximity Read ↗

Structural Analysis of the SARS-CoV-2 Spike N-Terminal Domain Across Wild-Type and Recent Variants: A Comparative Study.Semantic proximity Read ↗

Designing of epitope-based vaccine from the conserved region of spike glycoprotein of SARS-CoV-2Semantic proximity Read ↗

Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikesSemantic proximity Read ↗

Antiviral Peptides as Promising Therapeutics against SARS-CoV-2Semantic proximity Read ↗

Anti-viral chimeric protein RetroMAD1™ potently block SARS-CoV-2 viral entry and propagationSemantic proximity Read ↗

Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.Semantic proximity Read ↗

Insight into molecular characteristics of SARS-CoV-2 spike protein following D614G point mutation, a molecular dynamics study.Semantic proximity Read ↗

Dynamics prediction of emerging notable spike protein mutations in SARS-CoV-2 implies a need for updated vaccines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.